article thumbnail

What is Going on in Billing Compliance for Clinical Trials?

ACRP blog

Clinical trial billing compliance—ensuring that charges for therapies and other study-related elements are sent to the appropriate party—is a key concern for academic medical centers and other research organizations. Are you calculating fair market value correctly? Do you lose revenue in research? appeared first on ACRP.

article thumbnail

Why hasn’t pharma embraced email marketing?

World of DTC Marketing

SUMMARY : DTC marketers are spending tens of millions of dollars on programmatic ads that are full of fraud and have low click-through rates but they have yet to embrace email marketing which has an average click-through rate of 3.43%. The key to effective email marketing is segmentation and personalization.

Marketing 289
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why Is FDA Issuing Fewer Marketing Violation Letters?

Pharma Marketing Network

The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled.

article thumbnail

Leading direct-to-consumer marketing companies for pharmaceuticals

Pharmaceutical Technology

Pharmaceutical companies hold permission to market their products directly to consumers. The direct-to-consumer marketing companies for pharmaceuticals are increasingly moving online as it supports the digitisation of information, enabling patients to take control of their health. No product is mentioned for help-seeking advertising.

Marketing 130
article thumbnail

Compliance to convenience: understanding the latest innovations in capsule formulation

Pharmaceutical Technology

Softgels have now achieved strong recognition in the prescription, consumer health and supplements markets. Fixed-dose combination (FDC) systems aim to increase patient compliance in therapies involving two or more active drugs. They also offer enhanced bioavailability, exact dosing and an extended shelf life. 200x260/0 (who.int).

article thumbnail

Versanis’ bimagrumab, first-in-class obesity therapy, enters Phase IIb of development

Pharmaceutical Technology

Bimagrumab is an activin receptor type 2B (ACVR2B or EC 2.7.11.30) antagonist that offers a unique mechanism of action within the obesity market. Furthermore, bimagrumab is a long-acting therapy, thus significantly reducing the number of treatment days in comparison to many currently marketed and late-stage pipeline therapies.

article thumbnail

What is Going on in Billing Compliance for Clinical Trials?

ACRP blog

Clinical trial billing compliance—ensuring that charges for therapies and other study-related elements are sent to the appropriate party—is a key concern for academic medical centers and other research organizations. Are you calculating fair market value correctly? Do you lose revenue in research? appeared first on ACRP.